AMPS (Atavistik Metabolite Protein Screening) platform discovers cryptic allosteric pockets for selective small-molecule drugs; ATV-1601 AKT1 inhibitor in HHT and JAK2 V617F MPN inhibitor in pipeline; cumulative $220M+
No detailed funding rounds available.
Total known funding: